These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36720995)

  • 21. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets.
    Estefanía E; Flores R; Gómez-Lozano N; Aguilar H; López-Botet M; Vilches C
    J Immunol; 2007 Apr; 178(7):4402-10. PubMed ID: 17371997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
    Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
    Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
    Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
    Front Genet; 2022; 13():845474. PubMed ID: 35273641
    [No Abstract]   [Full Text] [Related]  

  • 24. Activating KIR genes are associated with ankylosing spondylitis in Asian populations.
    Díaz-Peña R; Blanco-Gelaz MA; Suárez-Alvarez B; Martínez-Borra J; López-Vázquez A; Alonso-Arias R; Brüges-Armas J; Vidal-Castiñeira JR; López-Larrea C
    Hum Immunol; 2008 Jul; 69(7):437-42. PubMed ID: 18638658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study.
    Margolis DJ; Mitra N; Kim BS; Duke JL; Berna RA; Hoffstad OJ; Wasserman JR; Ferriola DA; Mosbruger TL; Wubbenhorst BS; Nathanson KL; Monos DS
    J Immunol; 2021 May; 206(9):2038-2044. PubMed ID: 33863792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.
    López-Hernández R; Campillo JA; Legaz I; Valdés M; Salama H; Boix F; Hernández-Martínez AM; Eguia J; González-Martínez G; Moya-Quiles MR; Minguela A; García-Alonso A; Carballo F; Muro M
    Microbiol Immunol; 2016 Nov; 60(11):787-792. PubMed ID: 27797112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killer-cell immunoglobulin-like receptors and cytomegalovirus reactivation during late pregnancy.
    Alvarado-Hernández DL; Benítez-Sánchez A; Rodríguez-Cuevas JS; Rosales-Saavedra T; Guerra-Palomares SE; Comas-García A; Noyola DE; García-Sepúlveda CA
    Int J Immunogenet; 2016 Aug; 43(4):189-99. PubMed ID: 27277336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA Alleles and KIR Genes in Romanian Patients with Chronic Hepatitis C.
    Ursu L; Calenic B; Diculescu M; Dima A; Constantinescu I
    J Gastrointestin Liver Dis; 2020 Oct; 29(4):595-601. PubMed ID: 33118540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity.
    Tukwasibwe S; Traherne JA; Chazara O; Jayaraman J; Trowsdale J; Moffett A; Jiang W; Nankabirwa JI; Rek J; Arinaitwe E; Nsobya SL; Atuheirwe M; Frank M; Godwin A; Jagannathan P; Cose S; Kamya MR; Dorsey G; Rosenthal PJ; Colucci F; Nakimuli A
    Malar J; 2021 Feb; 20(1):111. PubMed ID: 33632228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent Pregnancy Loss in Women with Killer Cell Immunoglobulin-Like Receptor KIR2DS1 is Associated with an Increased HLA-C2 Allelic Frequency.
    Dambaeva SV; Lee DH; Sung N; Chen CY; Bao S; Gilman-Sachs A; Kwak-Kim J; Beaman KD
    Am J Reprod Immunol; 2016 Feb; 75(2):94-103. PubMed ID: 26589762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
    Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
    N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
    Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
    Front Immunol; 2019; 10():734. PubMed ID: 31024561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.
    Houtchens KA; Nichols RJ; Ladner MB; Boal HE; Sollars C; Geraghty DE; Davis LM; Parham P; Trachtenberg EA
    Immunogenetics; 2007 Jul; 59(7):525-37. PubMed ID: 17464504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders.
    Carneiro VL; Lemaire DC; Bendicho MT; Souza SL; Cavalcante LN; Angelo AL; Freire SM; Mendes CM; Santana N; Lyra LG; Lyra AC
    Liver Int; 2010 Apr; 30(4):567-73. PubMed ID: 20456039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.
    Della Chiesa M; Romeo E; Falco M; Balsamo M; Augugliaro R; Moretta L; Bottino C; Moretta A; Vitale M
    Eur J Immunol; 2008 Aug; 38(8):2284-9. PubMed ID: 18624290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.